FibroBiologics Inc. Contracts & Agreements
46 Contracts & Agreements
- Business Finance (20 contracts)
- Business Operations (2)
- Human Resources (3)
- Intellectual Property (5)
- Real Estate (5)
- Uncategorized (11)
- Master Service Agreement, effective September 19, 2024, between FibroBiologics, Inc. and Charles River Laboratories, Inc (Filed With SEC on September 24, 2024)
- Amendment 2 to the Patent Assignment Agreement between SpinalCyte LLC and FibroBiologics, Inc., effective as of May 17, 2021 (Filed With SEC on August 7, 2024)
- Amendment 1 to the Intellectual Property Cross-License Agreement between SpinalCyte LLC and FibroBiologics, Inc., effective as of May 17, 2021 (Filed With SEC on August 7, 2024)
- Amendment 2 to Energy Research Park Industrial Lease between University of Houston System, as Landlord, and FibroBiologics, Inc., as Tenant, effective April 1, 2024 (Filed With SEC on June 18, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on June 4, 2024)
- Form of Warrant to be issued to Purchasers (Filed With SEC on June 4, 2024)
- Form of Placement Agent Agreement (Filed With SEC on June 4, 2024)
- Form of Warrant issued to Series B-1 Holders (Filed With SEC on April 26, 2024)
- Form of Placement Agent Agreement (Filed With SEC on April 26, 2024)
- Form of Warrant to be issued to Purchasers (Filed With SEC on April 26, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 26, 2024)
- Form of Warrant Agent Agreement (Filed With SEC on April 26, 2024)
- Employment Agreement effective from March 1, 2024, between FibroBiologics, Inc. and Ruben Garcia (Filed With SEC on March 15, 2024)
- Amendment 1 to Energy Research Park Industrial Lease between University of Houston System, as Landlord, and FibroBiologics, Inc., as Tenant, effective October 1, 2023 (Filed With SEC on March 15, 2024)
- Form of Warrant of FibroBiologics, Inc. issued pursuant to the GEM Agreement (Filed With SEC on March 15, 2024)
- Description of registrants securities (Filed With SEC on February 29, 2024)
- Engagement Letter between FibroBiologics, Inc. and Maxim Group LLC dated April 24, 2023 (Filed With SEC on January 22, 2024)
- Energy Research Park Industrial Lease between University of Houston System, as Landlord, and FibroBiologics, Inc., as Tenant, effective August 1, 2023 (Filed With SEC on November 28, 2023)
- Amendment 1 to Energy Research Park Industrial Lease between University of Houston System, as Landlord, and FibroBiologics, Inc., as Tenant, effective October 1, 2023 (Filed With SEC on November 28, 2023)
- Form of Stock Option Notice and Grant Agreement (Filed With SEC on November 28, 2023)
- Agreement Regarding Right of First Negotiation dated January 20, 2023 (Filed With SEC on November 28, 2023)
- Amendment 1 to the Patent Assignment Agreement, effective August 2, 2022 (Filed With SEC on November 28, 2023)
- IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021 (Filed With SEC on November 28, 2023)
- Form of Indemnification Agreement between the Registrant and each of its Directors and Executive Officers (Filed With SEC on November 28, 2023)
- Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
- Patent Assignment Agreement dated May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
- Share Purchase Agreement dated as of November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (Filed With SEC on November 28, 2023)
- Registration Rights Agreement dated November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (Filed With SEC on November 28, 2023)
- Bridge Note dated April 1, 2021, between SpinalCyte LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Sublease Agreement between United Fire & Casualty Company and FibroBiologics, Inc., effective October 5, 2022 (Filed With SEC on November 28, 2023)
- License Agreement, dated November 30, 2021, between K2 Biolabs, LLC and FibroBiologics, LLC (Filed With SEC on November 28, 2023)
- Amendment No. 1, effective July 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Amendment No. 2, effective August 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Amendment No. 3, effective October 1, 2022, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- Amendment No. 4, effective January 1, 2023, to the License Agreement between K2 Biolabs, LLC and FibroBiologics, Inc (Filed With SEC on November 28, 2023)
- 2022 Stock Plan (Filed With SEC on November 28, 2023)
- Employment Agreement effective from July 20, 2021, between FibroBiologics, LLC and Hamid Khoja (Filed With SEC on November 28, 2023)
- Employment Agreement effective from May 31, 2022, between FibroBiologics, Inc. and Mark Andersen (Filed With SEC on November 28, 2023)
- Intellectual Property Cross-License Agreement dated as of May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 7, 2023)
- Agreement Regarding Right of First Negotiation dated January 20, 2023 (Filed With SEC on November 7, 2023)
- Amendment 1 to the Patent Assignment Agreement, effective August 2, 2022 (Filed With SEC on November 7, 2023)
- IP Transfer Agreement between SpinalCyte, LLC and FibroBiologics, LLC, dated as of May 17, 2021 (Filed With SEC on November 7, 2023)
- 2022 Stock Plan (Filed With SEC on November 7, 2023)
- Registration Rights Agreement dated November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (Filed With SEC on November 7, 2023)
- Share Purchase Agreement dated as of November 12, 2021, by and among FibroBiologics, LLC GEM Global Yield LLC SCS and GEM Yield Bahamas Limited (Filed With SEC on November 7, 2023)
- Patent Assignment Agreement dated May 17, 2021, between SpinalCyte LLC and FibroBiologics, LLC (Filed With SEC on November 7, 2023)
